An interventional study of topical application of the "AromaQoR" formulation and topical application of sweet almond vegetable oil in Thoracic Surgical Procedures, Postoperative Recovery and Pain, sponsored by University Hospital, Toulouse. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-09.
Sponsored by University Hospital, Toulouse · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Pain by University Hospital, Toulouse — 5 open to participants now, 5 under way, none of them phase 3. Pain · University Hospital, Toulouse.
Among the 22 studies in Pain by University Hospital, Toulouse, this one is the 3rd largest by planned enrollment of the 16 interventional ones that give a count, is one of 5 that started in 2026, is one of 9 with no phase, and was the 20th registered.
10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.
Browse Pain studies →5 of the 22 studies in Pain by University Hospital, Toulouse are open now, in 1 country. Recruiting first, the newest first:
University Hospital, Toulouse · Sites in France
Ages 18+ · Women only
University Hospital, Toulouse · Sites in France
Ages 18+
University Hospital, Toulouse
Ages 18+ · Women only
University Hospital, Toulouse · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 930 Pain studies recruiting now, 384 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 220 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 5 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 124 is above the median of 66 across 8,512 interventional studies indexed under Pain.
Median enrollment 29 across the 16 interventional studies, 116 across the 6 observational. Of the 16 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Hospital, Toulouse is the lead sponsor of 809 studies on the registry; 211 are open to participants now.
2 of the studies in Pain by University Hospital, Toulouse that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07627490University Hospital, ToulouseThe Potential of Transcutaneous Electrical Nerve Stimulation to Improve Pain Experienced During Posterior Branch Blocks in Patients With Lumbar Posterior Joint Syndrome | 2026-12-01 |
| NCT07924033University Hospital, ToulousePredicting Perineal Pain During the Expulsive Phase Under Obstetric Epidural Analgesia | 2027-05 |
Add all 2 to your calendar (.ics) → With an account.
Among the 22 studies in Pain by University Hospital, Toulouse, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The key to early surgery recovery lies in optimal and immediate control of postoperative pain. Despite standard pain management protocols, lung resection is often associated with acute, neuropathic, or chronic pain, compounded by the side effects of morphine-based treatments. In this context, aromatherapy can provide complementary support, both to alleviate pain and to improve the quality of recovery after surgery.
Lung cancer is the leading cause of cancer mortality in France. Lung resection is the standard treatment for early-stage or locally advanced non-small cell lung cancer, but it remains a very painful procedure with a high risk of complications and a morbidity rate of around 30%. Enhanced Recovery After Surgery (ERAS) protocols have reduced morbidity and mortality through standardized perioperative care. Early and optimal pain control is essential to promote rapid mobilization, limit complications, and prevent chronicity. Despite multimodal management, acute, neuropathic, and chronic pain remain common after lung resection and impair the quality of recovery.
Complementary approaches, such as aromatherapy, are increasingly used to support conventional treatments, sometimes reducing the use of morphine derivatives and their adverse effects. Lavender (Lavandula angustifolia) essential oil and its main components, linalool and linalyl acetate, whose antinociceptive, anti-inflammatory, and anxiolytic properties are well documented, is of particular interest. Our study will evaluate the effect of daily application of 5% lavender essential oil (AromaQoR) to the skin around the surgical wound for three days following surgery on improving the quality of recovery.
The surgeon preselects eligible patients and the coordinating nurse ("IDEC") presents the study to them during a preoperative interview. The day before surgery, the IDEC obtains consent, has the QoR-15F completed, and performs an AromaQoR skin test. On the morning of surgery, only patients without allergic reactions are included and then randomized into two groups: placebo (PL) or intervention (AT). From D0 to D2, the intervention (placebo or AromaQoR) is applied every evening, while the QoR-15F questionnaire is collected daily by a different team. Pain scores (EN, DN4) are measured regularly, with only those taken the following morning being recorded, and all rescue analgesics are recorded. A post-operative consultation is conducted three weeks after discharge, during which the IDEC measures the EN and DN4 and collects the QoR-15F questionnaire completed by the patient. This consultation marks the end of follow-up for the trial.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The PL group: In addition to standard pain relief treatments, the PL group will receive topical application of sweet almond oil around the operated area at 9 p.m. from day 0 to day 2.
Other: topical application of sweet almond vegetable oil
The AT group: in addition to standard analgesic treatments, the AT group will receive topical application of the "AromaQoR" formulation, containing lavender essential oil (Lavandula angustifolia) diluted to 5% in sweet almond vegetable oil around the operated area at 9 p.m. from day 0 to day 2.
Other: topical application of the "AromaQoR" formulation
topical application of the "AromaQoR" formulation, containing lavender essential oil (Lavandula angustifolia) diluted to 5% in sweet almond vegetable oil around the operated area
topical application of sweet almond oil around the operated area
Change in the total QoR-15F
Change in the total QoR-15F score (Recovery Quality score) on postoperative day 2 (measured in the evening, as it assesses, among other things, activity during the day) compared to the baseline value obtained the day before surgery, day -1, between the two groups.
Time frame: day 2
Change in the total QoR-15F score (Recovery Quality) on postoperative Day 1 (evening)
Change in the total QoR-15F score (Recovery Quality) on postoperative D1 (evening) compared to the baseline value on Day-1
Time frame: Day 1
Change in the total QoR-15F score (Recovery Quality) on postoperative Day 3 (evening)
Change in the total QoR-15F score (Recovery Quality) on postoperative Day 3 (evening) compared to the baseline value on Day-1
Time frame: Day 3
Change in the total QoR-15F score 3 weeks after discharge (postoperative consultation)
Change in the total QoR-15F score 3 weeks after discharge (postoperative consultation) compared to the baseline value on D-1
Time frame: Week 3
Change in pain score at Day 0 (= day of surgery)
pain score measured by numerical scale (EN) at each measurement time point compared to Day-1
Time frame: Day 0
Change in pain score at from postoperative Day 1 to postoperative Day 3 (morning, evening, night)
pain score measured by numerical scale (EN) at each measurement time point compared to Day-1
Time frame: Day 3
Change in pain score at 3 weeks after discharge (day of postoperative consultation).
pain score measured by numerical scale (EN) at each measurement time point compared to Day-1
Time frame: week 3
Quantification of the consumption of Nefopam
number of ampoules consumed per day.
Time frame: day 3
Quantification of the consumption of morphine derivatives (prescribed as a second-line treatment if Nefopam is ineffective)
number of tablets consumed per day
Time frame: day 3
Started Aug 2026 (actual). Primary completion is estimated for Jun 2028, 22 months after the start.
Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's planned 22 months is above that.
Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
Start moved once since we started tracking on Sep 25, 2026: Jun 2026 → Aug 2026, on Nov 9, 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Toulouse →